pindolol has been researched along with Panic Attacks in 3 studies
Pindolol: A moderately lipophilic beta blocker (ADRENERGIC BETA-ANTAGONISTS). It is non-cardioselective and has intrinsic sympathomimetic actions, but little membrane-stabilizing activity. (From Martindale, The Extra Pharmocopoeia, 30th ed, p638)
pindolol : A member of the class of indols which is the 2-hydroxy-3-(isopropylamino)propyl ether derivative of 1H-indol-4-ol.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD)." | 9.09 | Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. ( Dannon, PN; Dolberg, OT; Grunhaus, L; Hirschmann, S; Iancu, I; Zohar, J, 2000) |
| "The objective of this study was to determine the efficacy of pindolol as an augmentor of fluoxetine in treatment-resistant panic disorder (PD)." | 5.09 | Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial. ( Dannon, PN; Dolberg, OT; Grunhaus, L; Hirschmann, S; Iancu, I; Zohar, J, 2000) |
| "the β-adrenergic and 5-HT(1A) receptor antagonist pindolol has been used in combination with antidepressant drugs, to shorten the time of onset of clinical efficacy and/or increase the proportion of responders in depressive and anxiety disorders." | 3.76 | Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze. ( Audi, EA; Graeff, FG; Roncon, CM; Sela, VR; Zangrossi, H, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernik, M | 1 |
| Ramos, RT | 1 |
| Hetem, LAB | 1 |
| Graeff, F | 1 |
| Sela, VR | 1 |
| Roncon, CM | 1 |
| Zangrossi, H | 1 |
| Graeff, FG | 1 |
| Audi, EA | 1 |
| Hirschmann, S | 1 |
| Dannon, PN | 1 |
| Iancu, I | 1 |
| Dolberg, OT | 1 |
| Zohar, J | 1 |
| Grunhaus, L | 1 |
2 trials available for pindolol and Panic Attacks
| Article | Year |
|---|---|
Effect of single doses of pindolol and d-fenfluramine on flumazenil-induced anxiety in panic disorder patients.
Topics: Adult; Anxiety; Female; Fenfluramine; Flumazenil; GABA Modulators; Humans; Male; Middle Aged; Panic | 2019 |
Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anti-Anxiety Agents; Double-Blind Method; | 2000 |
1 other study available for pindolol and Panic Attacks
| Article | Year |
|---|---|
Pindolol potentiates the panicolytic effect of paroxetine in the elevated T-maze.
Topics: Adrenergic beta-Antagonists; Animals; Antidepressive Agents, Second-Generation; Anxiety Disorders; D | 2010 |